355 related articles for article (PubMed ID: 8868981)
21. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354
[TBL] [Abstract][Full Text] [Related]
22. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
23. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
25. Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction.
Yoshitomi Y; Nishikimi T; Kojima S; Kuramochi M; Takishita S; Kangawa K; Matsuo H
Int J Cardiol; 1998 Apr; 64(2):153-60. PubMed ID: 9688434
[TBL] [Abstract][Full Text] [Related]
26. Biochemical detection of left-ventricular systolic dysfunction.
McDonagh TA; Robb SD; Murdoch DR; Morton JJ; Ford I; Morrison CE; Tunstall-Pedoe H; McMurray JJ; Dargie HJ
Lancet; 1998 Jan; 351(9095):9-13. PubMed ID: 9433422
[TBL] [Abstract][Full Text] [Related]
27. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography.
Ng LL; Loke I; Davies JE; Khunti K; Stone M; Abrams KR; Chin DT; Squire IB
Eur J Heart Fail; 2003 Dec; 5(6):775-82. PubMed ID: 14675856
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
[TBL] [Abstract][Full Text] [Related]
29. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
[TBL] [Abstract][Full Text] [Related]
30. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation.
Sutton TM; Stewart RA; Gerber IL; West TM; Richards AM; Yandle TG; Kerr AJ
J Am Coll Cardiol; 2003 Jun; 41(12):2280-7. PubMed ID: 12821260
[TBL] [Abstract][Full Text] [Related]
31. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
Choy AM; Darbar D; Lang CC; Pringle TH; McNeill GP; Kennedy NS; Struthers AD
Br Heart J; 1994 Jul; 72(1):16-22. PubMed ID: 7741839
[TBL] [Abstract][Full Text] [Related]
32. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
Daggubati S; Parks JR; Overton RM; Cintron G; Schocken DD; Vesely DL
Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
[TBL] [Abstract][Full Text] [Related]
34. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction.
Rademaker MT; Cameron VA; Charles CJ; Espiner EA; Nicholls MG; Pemberton CJ; Richards AM
Am J Physiol Heart Circ Physiol; 2000 Mar; 278(3):H731-40. PubMed ID: 10710340
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population.
Groenning BA; Raymond I; Hildebrandt PR; Nilsson JC; Baumann M; Pedersen F
Heart; 2004 Mar; 90(3):297-303. PubMed ID: 14966052
[TBL] [Abstract][Full Text] [Related]
36. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
37. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.
Lim TK; Ashrafian H; Dwivedi G; Collinson PO; Senior R
Eur J Heart Fail; 2006 Jan; 8(1):38-45. PubMed ID: 16115798
[TBL] [Abstract][Full Text] [Related]
38. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
Wong F; Siu S; Liu P; Blendis LM
Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.
Omland T; Bonarjee VV; Nilsen DW; Sundsfjord JA; Lie RT; Thibault G; Dickstein K
Br Heart J; 1993 Nov; 70(5):409-14. PubMed ID: 8260270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
